Old Web
English
Sign In
Acemap
>
authorDetail
>
Sarah Kulke
Sarah Kulke
Biogen Idec
Recombinant factor viii
Dosing
Population
Medicine
Von Willebrand factor
3
Papers
43
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Recombinant factor VIII Fc fusion protein: extended-interval dosing maintains low bleeding rates and correlates with von Willebrand factor levels
2014
Journal of Thrombosis and Haemostasis
A. Shapiro
Margaret V. Ragni
Roshni Kulkarni
J. Oldenberg
A. Srivastava
Doris Quon
K. J. Pasi
Hideji Hanabusa
Ingrid Pabinger
Johnny Mahlangu
Patrick F. Fogarty
David Lillicrap
Sarah Kulke
James Potts
Srividya Neelakantan
Ivan Nestorov
Shuanglian Li
Jennifer A. Dumont
Haiyan Jiang
Aoife Brennan
Glenn F. Pierce
Show All
Source
Cite
Save
Citations (42)
The Bleeding Tendency In Relation To Predicted FVIII Activity Levels In Severe Hemophilia A Patients Treated With Recombinant Factor VIII Fc Fusion Protein
2013
Blood
James Potts
Shuanglian Li
Ping Wang
Sarah Kulke
Glenn F. Pierce
Haiyan Jiang
Show All
Source
Cite
Save
Citations (1)
Dosing Long-Lasting Recombinant Factor VIII Fc Fusion Protein: Experience In The A-LONG Study
2013
Blood
Margaret V. Ragni
Roshni Kulkarni
Sarah Kulke
James Potts
Srividya Neelakantan
Ivan Nestorov
Jennifer A. Dumont
Haiyan Jiang
Aoife Brennan
Glenn F. Pierce
Show All
Source
Cite
Save
Citations (0)
1